Asunto(s)
Benzazepinas/farmacología , Piridinas/farmacología , Receptores de Vitronectina/antagonistas & inhibidores , Animales , Benzazepinas/síntesis química , Benzazepinas/farmacocinética , Disponibilidad Biológica , Resorción Ósea/prevención & control , Adhesión Celular/efectos de los fármacos , Línea Celular , Semivida , Humanos , Imitación Molecular , Osteoclastos/efectos de los fármacos , Osteoclastos/metabolismo , Piridinas/síntesis química , Piridinas/farmacocinética , Ratas , Estereoisomerismo , Distribución TisularRESUMEN
Linear and convergent routes for the large-scale preparation of the hematoregulatory nonapeptide (Glp-Glu-Asp)2-DAS-(Lys)2 (2, SK&F 107647) were investigated. A convergent approach ('3 + 2'-route employing Boc-and benzyl ester protecting groups) was selected for the preparation of multihundred-gram quantities of 2. Key steps were the preparation and the coupling of tripeptide hydrochloride (HCl.H)2-DAS-(Lys(Z)-OBn)2 (6, DAS-2,7-L,L-diaminosuberic acid) and tripeptide Glp-Glu(OBn)-Asp(OBn)-OH (26). Several coupling reagents were investigated in order to reduce the amount of epimerization of this fragment coupling. TDBTU [O-(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl-1,1,3,3-tetrameth yluronium tetrafluoroborate] was identified as the condensation reagent of choice. Using this synthetic route > 97% pure final product in an overall yield of 35% calculated on di-Boc protected 2,7-L,L-diaminosuberic acid was prepared.